High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. [electronic resource]
- Journal of clinical microbiology Mar 2006
- 1059-64 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0095-1137
10.1128/JCM.44.3.1059-1064.2006 doi
Base Sequence Ciprofloxacin--pharmacology Cross Infection--drug therapy DNA Gyrase--genetics DNA Topoisomerase IV--genetics DNA, Bacterial--genetics Drug Resistance, Bacterial--genetics Enterococcus faecium--drug effects Genes, Bacterial Genomic Islands Genotype Gram-Positive Bacterial Infections--drug therapy Humans Models, Biological Point Mutation Virulence--genetics